Naltrexone-bupropion is another combination anti-obesity medicine
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are prescription drugs that mimic or boost the effects of the glucagon-like peptide-1 (GLP-1), which is a hormone released in response to eating
doi:10.1016/j.celrep.2024.114501 28
However, room temperature storage must not exceed the specified temperature limits, and medications should never be exposed to direct sunlight or heat sources such as windowsills, car interiors, or near appliances
GLP-1 receptor agonists enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release, and slow gastric emptying
Economic impacts of overweight and obesity: current and future estimates for 161 countries